Pacific Bio (PACB) Q3 Revenue Misses Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 2.53 +0.09 (3.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $14.00 | |||
| Open | $2.53 | 52 Week Low | $6.61 | |||
| Day High | $2.57 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $-1.26 | |||
| Volume | 661,823 | |||||
